RxDoctor Payments Data

Scott Culp, DO

Family Medicine · North Wales, PANPI 1861482275

Payments from drug & device makers

$3,226in general payments, 2019–2025

Across 194 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$340
  • Novo Nordisk$263
  • Lilly USA, LLC$239
  • Corcept Therapeutics$230
  • AstraZeneca$219
  • plus $838 from 16 others

What the payments were for

  • Food & beverage$3,13797%
  • Education$893%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,226 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$74,483
Medicare patients
180
Services billed
836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide78$102,796
OzempicSemaglutide31$31,283
JardianceEmpagliflozin13$17,488
JanuviaSitagliptin Phosphate15$15,978
FarxigaDapagliflozin Propanediol13$13,886
Rosuvastatin Calcium206$3,721
SynthroidLevothyroxine Sodium48$3,555
Atorvastatin Calcium298$2,820
Testosterone16$2,612
Fluticasone-SalmeterolFluticasone Propion/Salmeterol26$2,249
Pitavastatin Calcium13$2,225
Levothyroxine Sodium175$2,082
Metoprolol Succinate177$1,922
Metformin Hcl ErMetformin Hcl91$1,765
Albuterol Sulfate HfaAlbuterol Sulfate47$1,660

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$239$102,79678 claims
Novo NordiskOzempic$263$31,28331 claims
AstraZenecaFarxiga$219$13,88613 claims
AbbVieSynthroid$1,098$3,55548 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in North Wales

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →